BURBANK, Calif., May 29, 2020 /PRNewswire/ -- Quanta, Inc. (OTCPK:QNTA), an applied sciences company based on a patented quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, announced an update for shareholders relating to recent corporate events and SEC filings.
Eric Rice, Chief Executive Officer of Quanta commented, "We have taken several actions to optimize our capital structure, including the refunding of a senior secured debt facility with terms that are more flexible and beneficial to us. The two convertible notes that remain are held by high quality, friendly, long-term shareholders, with conversion features that are also favorable to the company."
"Also as we announced earlier this week, we have adjusted the pricing on certain options for our employees, to reward and compensate them for losses experienced due to the strict stay-at-home regulations mandated by the state of California for more than two months. We are extremely proud of all our team members for staying focused on the big picture in a time of so much uncertainty. All of our employee options have a 3 to 4-year vesting schedule, which made this a simple, cost-effective, non-dilutive way to thank our valued team members."
The company also announced that it has begun to ship its own Quanta branded hand sanitizer product to one of its distribution partners, with over two hundred retail locations throughout the Midwestern United States. The first order, for 5,000 units, is expected to be on store shelves in 2 weeks and is part of a branding and sales campaign that adds an incremental new revenue stream for Quanta.
The company is also taking actions to improve shareholder communications by launching a new Twitter account (QNTAstock) today and a new investor relations website in the coming weeks.
Quanta, Inc. ("Quanta") is a cutting-edge technology platform whose patented, proprietary technology harnesses advances in quantum biology to increase the potency of active ingredients. Currently, Quanta supports product formulations in pain management, anti-inflammation, skincare, anti-aging, nutritional supplements, and plant-based consumables. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste and facilitate healthier, more sustainable consumption.
The established resonance theory behind Quanta's polarization process has many potential applications. From potentiating bio-ingredients to produce more-effective carbon-trapping plants to transformative anti-aging solutions Quanta's technology has the opportunity to upend how commercial products are made and the benefits from them. Already we see multi-trillion-dollar global industries benefiting from Quanta's technology. You can find more about Quanta at https://buyquanta.com/.
Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management including statements regarding the Company's expected results of operations or liquidity; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance; and statements of management's goals and objectives and other similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "will," "should," "could," and similar expressions. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
Darrow Associates, Inc.
Peter Seltzberg, Managing Director, IR
SOURCE Quanta, Inc.